Sanima Capital Issues Sanima Equity Fund from Nov 28 to Dec 1, 2017 !

Sanima Equity Fund is being floated its public issue of 120 million (12 crore) unit shares worth Rs. 1.20 billion (arba) for 4 days starting from November 28th 2017 (Mangsir 12th, 2074) till December 1st 2017 (Mangsir 15th, 2074).

The Equity Fund is a closed-end 7-years equity oriented mutual fund scheme with fund size of Rs. 1.20 billion (arba). The mutual fund is managed by Sanima Capital Limited, a subsidiary company of Sanima Bank Limited (SANIMA), its fund sponsor.

Out of the total units, 15 percent, i.e., 18 million mutual fund units have been allocated to the promoter of the mutual fund, Sanima Bank and the remaining units will be issued to the general public.

Check the link below to see or download the NOTICE:

NOTICE LINK

The offer will close on December 1st 2017 (Mangsir 15th, 2074) at the earliest, else the maximum closing date for the offer is December 12th 2017 (Mangsir 26th, 2074).

Interested people must apply for a minimum of 100 units of share and can apply maximum for up to 2.4 million unit of shares.

Check the link below to see or download the AAHWAANPATRA RELEASE:

AAHWAANPATRA LINK

The mutual fund will be issuing a total of 12 crore unit of ordinary shares worth Rs. 1.20 billion (arba) at face value of Rs. 10 per unit.

Check the link below to see or download the PROSPECTUS:

PROSPECTUS LINK

Check the link below to see or download the PRESS RELEASE:

PRESS RELEASE LINK

Interested applicants can apply through ASBA-approved banks from all 75 districts across the country.

Check the link below to apply using online step-by-step ASBA SERVICE:

ASBA ONLINE LINK

ShareUpdateNepal: Wednesday November 29th, 2017 !

Click here to see why mutual funds are best to invest

Click here to see the list of ASBA member BFIs

Are Vitamin Supplements for Pregnant Women a Waste of Money?

It is essential that an expectant mother receives adequate nutrition to promote the healthy development of her unborn child. To this end, the market is awash with maternal vitamin supplements. A new review asks whether these pills are as necessary as they claim to be.

Maternal deficiency of certain nutrients has been linked to a number of negative health consequences for mother and child.

Risks include restricted fetal growth, low birth weight, skeletal deformities, and pre-eclampsia.

These well-known dangers support a huge vitamin, mineral, and micronutrient industry aimed at pregnant women.

Typically, these tablets will contain 20 or more vitamins and minerals, often including a range of B vitamins, C, D, E, K, iodine, folic acid, magnesium, zinc, selenium, and copper.

Read more: Are Vitamin Supplements for Pregnant Women a Waste of Money?

Are pregnancy supplements as essential to maternal health as they claim to be?

Source: medicalnewstoday